Prolactin modulates the naive B cell repertoire

被引:108
作者
Peeva, E
Michael, D
Cleary, J
Rice, J
Chen, X
Diamond, B
机构
[1] Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA
[2] Yeshiva Univ Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA
关键词
D O I
10.1172/JCI200316530
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Prolactin is a peptide hormone produced by the anterior pituitary gland that is critical in lactation. Prolactin can also be produced by lymphocytes, and both B and T cells express prolactin receptors. These findings have suggested that prolactin has immunomodulatory functions. Studies in spontaneously autoimmune hosts have demonstrated a role for prolactin in augmenting autoreactivity. We chose to analyze prolactin effects on anti-DNA B cells in nonspontaneously autoimmune female BALB/c mice transgenic for the heavy chain of an anti-DNA antibody. Treatment with prolactin for 4 weeks induced a lupus-like phenotype with an increased number of transgene-expressing B cells, elevated serum anti-DNA antibody titers, and glomerular immunoglobulin deposits. Prolactin caused a decrease in the population of transitional B cells and an increase in mature follicular and marginal zone B cells. The DNA-reactive B cells had a follicular cell phenotype. Anti-DNA hybridomas demonstrated that prolactin alters selection of the naive B cell repertoire. The expansion and activation of anti-DNA B cells in prolactin-treated R4A-gamma2b BALB/c mice was dependent on the presence of CD4(+)T cells. Finally, treatment with prolactin was unable to break tolerance in R4A-gamma2b transgenic C57Bl/6 mice, suggesting that responsiveness of the immune system to prolactin is genetically determined.
引用
收藏
页码:275 / 283
页数:9
相关论文
共 72 条
  • [1] AHMED SA, 1985, AM J PATHOL, V121, P531
  • [2] Allen SH, 1996, LUPUS, V5, P30, DOI 10.1177/096120339600500107
  • [3] Bromocriptine in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled study
    Alvarez-Nemegyei, J
    Cobarrubias-Cobos, A
    Escalante-Triay, F
    Sosa-Munoz, J
    Miranda, JM
    Jara, LJ
    [J]. LUPUS, 1998, 7 (06) : 414 - 419
  • [4] Extrapituitary prolactin: Distribution, regulation, functions, and clinical aspects
    BenJonathan, N
    Mershon, JL
    Allen, DL
    Steinmetz, RW
    [J]. ENDOCRINE REVIEWS, 1996, 17 (06) : 639 - 669
  • [5] HYPERPROLACTINEMIA - EVALUATION AND MANAGEMENT
    BLACKWELL, RE
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1992, 21 (01) : 105 - 124
  • [6] Prolactin, a lymphocyte growth and survival factor
    Buckley, AR
    [J]. LUPUS, 2001, 10 (10) : 684 - 690
  • [7] Bynoe MS, 1999, EUR J IMMUNOL, V29, P1304, DOI 10.1002/(SICI)1521-4141(199904)29:04<1304::AID-IMMU1304>3.0.CO
  • [8] 2-6
  • [9] Estrogen up-regulates Bcl-2 and blocks tolerance induction of naive B cells
    Bynoe, MS
    Grimaldi, CM
    Diamond, B
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (06) : 2703 - 2708
  • [10] The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21
    Cariappa, A
    Tang, M
    Parng, C
    Nebelitskiy, E
    Carroll, M
    Georgopoulos, K
    Pillai, S
    [J]. IMMUNITY, 2001, 14 (05) : 603 - 615